Interferon-alpha2 (myeloid-specific expression)
Assets acting on this target.
- Class
- Gene therapy (lentiviral vector delivering interferon-alpha2 to myeloid cells)
- Notes
- verified in session 2026-08-25 (owner-delegated review); source: https://clinicaltrials.gov/study/NCT03866109
Related mechanisms
Interferon-alpha2 (IFN-alpha2) expression in myeloid cells (1)Type I interferon receptor (8)Interferon beta receptor (type I IFN signaling) (3)Autologous tumor neoantigens (polyclonal, patient-specific) (2)CD3 x tumor antigen x immune checkpoint (multi-specific) (1)CLEC7A (Dectin-1) on myeloid cells (plus tumor antigen) (1)